TruScreen Group Limited (TRU.AX)
AUD 0.02
(0.0%)
AUD 0.02
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | -2.54 Million NZD | 13.4% |
| 2023 | -2.94 Million NZD | 66.82% |
| 2022 | -8.86 Million NZD | -156.6% |
| 2021 | -3.45 Million NZD | -25.89% |
| 2020 | -2.74 Million NZD | 21.01% |
| 2019 | -3.47 Million NZD | 33.19% |
| 2018 | -5.2 Million NZD | -48.47% |
| 2017 | -3.5 Million NZD | -176.63% |
| 2016 | -1.26 Million NZD | -87.76% |
| 2015 | -674.44 Thousand NZD | 71.1% |
| 2014 | -2.33 Million NZD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -634.66 Thousand NZD | -17.73% |
| 2024 Q3 | -290.95 Thousand NZD | 54.16% |
| 2024 FY | -2.54 Million NZD | 13.4% |
| 2024 Q2 | -634.66 Thousand NZD | 0.0% |
| 2024 Q4 | -290.95 Thousand NZD | -0.0% |
| 2023 Q2 | -621.1 Thousand NZD | 0.0% |
| 2023 Q3 | -539.07 Thousand NZD | 13.21% |
| 2023 Q1 | -621.1 Thousand NZD | 35.66% |
| 2023 FY | -2.94 Million NZD | 66.82% |
| 2023 Q4 | -539.07 Thousand NZD | 0.0% |
| 2022 Q4 | -965.32 Thousand NZD | 0.0% |
| 2022 FY | -8.86 Million NZD | -156.6% |
| 2022 Q3 | -965.32 Thousand NZD | -45.63% |
| 2022 Q2 | -662.86 Thousand NZD | 0.0% |
| 2022 Q1 | -662.86 Thousand NZD | 16.01% |
| 2021 Q1 | -723.74 Thousand NZD | 15.96% |
| 2021 FY | -3.45 Million NZD | -25.89% |
| 2021 Q2 | -723.74 Thousand NZD | 0.0% |
| 2021 Q4 | -789.21 Thousand NZD | 0.0% |
| 2021 Q3 | -789.21 Thousand NZD | -9.05% |
| 2020 Q3 | -861.14 Thousand NZD | -73.74% |
| 2020 Q2 | -495.63 Thousand NZD | 0.0% |
| 2020 FY | -2.74 Million NZD | 21.01% |
| 2020 Q4 | -861.14 Thousand NZD | 0.0% |
| 2020 Q1 | -495.63 Thousand NZD | 37.77% |
| 2019 Q3 | -796.44 Thousand NZD | -16.77% |
| 2019 Q1 | -682.05 Thousand NZD | 34.28% |
| 2019 Q2 | -682.05 Thousand NZD | 0.0% |
| 2019 Q4 | -796.44 Thousand NZD | 0.0% |
| 2019 FY | -3.47 Million NZD | 33.19% |
| 2018 FY | -5.2 Million NZD | -48.47% |
| 2018 Q3 | -1.03 Million NZD | -23.87% |
| 2018 Q4 | -1.03 Million NZD | 0.0% |
| 2018 Q1 | -837.8 Thousand NZD | 18.52% |
| 2018 Q2 | -837.8 Thousand NZD | 0.0% |
| 2017 Q2 | -651.83 Thousand NZD | 0.0% |
| 2017 Q4 | -1.02 Million NZD | 0.0% |
| 2017 FY | -3.5 Million NZD | -176.63% |
| 2017 Q3 | -1.02 Million NZD | -57.75% |
| 2017 Q1 | -651.83 Thousand NZD | -51.19% |
| 2016 Q1 | -258.35 Thousand NZD | -642.51% |
| 2016 FY | -1.26 Million NZD | -87.76% |
| 2016 Q3 | -431.12 Thousand NZD | -66.88% |
| 2016 Q4 | -431.12 Thousand NZD | 0.0% |
| 2016 Q2 | -258.35 Thousand NZD | 0.0% |
| 2015 Q2 | -257 Thousand NZD | 0.0% |
| 2015 Q3 | 47.62 Thousand NZD | 118.53% |
| 2015 FY | -674.44 Thousand NZD | 71.1% |
| 2015 Q4 | 47.62 Thousand NZD | 0.0% |
| 2015 Q1 | -257.01 Thousand NZD | 0.0% |
| 2014 FY | -2.33 Million NZD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| 4DMedical Limited | -27.96 Million AUD | 90.891% |
| Adherium Limited | -11.98 Million AUD | 78.744% |
| Aroa Biosurgery Limited | -9.78 Million AUD | 73.972% |
| Atomo Diagnostics Limited | -4.36 Million AUD | 41.589% |
| Anteris Technologies Ltd | -66.63 Million AUD | 96.177% |
| Control Bionics Limited | -5.92 Million AUD | 57.034% |
| CardieX Limited | -4.63 Million AUD | 45.021% |
| Compumedics Limited | -269 Thousand AUD | -847.055% |
| Cochlear Limited | 521.5 Million AUD | 100.489% |
| CleanSpace Holdings Limited | -4.81 Million AUD | 47.079% |
| Cyclopharm Limited | -9.22 Million AUD | 72.383% |
| EMVision Medical Devices Ltd | -1.61 Million AUD | -57.803% |
| Nova Eye Medical Limited | -3.79 Million AUD | 32.906% |
| HeraMED Limited | -6.42 Million AUD | 60.367% |
| Imricor Medical Systems, Inc. | -17.57 Million AUD | 85.505% |
| ImpediMed Limited | -19.03 Million AUD | 86.617% |
| InhaleRx Limited | -1.38 Million AUD | -83.743% |
| LBT Innovations Limited | -4.74 Million AUD | 46.254% |
| Micro-X Limited | -13.02 Million AUD | 80.444% |
| Neurotech International Limited | -5.58 Million AUD | 54.384% |
| OncoSil Medical Limited | -11.98 Million AUD | 78.742% |
| PolyNovo Limited | 1.16 Million AUD | 319.052% |
| Respiri Limited | -7 Million AUD | 63.607% |
| SomnoMed Limited | -3.84 Million AUD | 33.679% |
| Universal Biosensors, Inc. | -16.68 Million AUD | 84.727% |
| Uscom Limited | -2.4 Million AUD | -5.957% |
| Visioneering Technologies, Inc. | -5.85 Million AUD | 56.482% |